UCLA-Amity Parolee Health Promotion Study

Completed · Not applicable

Conditions studied: Hepatitis B, Hepatitis C, HIV, Drug Addiction

In brief

The purpose of this study is to conduct a prospective, three-group study that randomly assigns 700 parolees, in a community residential drug treatment program, to enter one of three groups: 1) a PCPC (Parolee Comprehensive Care + Phone Coaching Program), which includes nurse case management and specialized hepatitis education sessions and the hepatitis A/B (HAV/HBV) vaccination series (to all eligible) and coach-facilitated mentoring (mostly by cell-phone); 2) a Parolee Brief Hepatitis Education + HBV vaccination + Phone Coaching (PBCP) Program, which includes brief hepatitis/HIV education, HAV/HBV vaccination and coach-facilitated mentoring; or 3) a Usual Care (UC) control program, which includes brief general health information, one-on-one coaching and the HAV/HBV vaccine.

Key facts

Study ID

NCT01844414

Run by

University of California, Los Angeles

People needed

600

Starts

2010-02-01

Expected to finish

2015-05-01

Last updated by the study team

2015-05-28

Who can join

Age: 18 and older, up to 60. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Parolees enrolled in Amity's Amistad's program;
• Age 18-60;
• Discharged from prison or jail within the last six months;
• History of drug use 12 months prior to most recent incarceration;
• Previously homeless prior to most recent incarceration; and
• Willing to provide informed consent

You may not qualify if…

• Monolingual speakers of languages other than English; and
• Persons judged to be cognitively impaired by the research staff.

Where it is running

• Amistad de Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.